Your browser doesn't support javascript.
loading
Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure.
Yang, Sijie; Yu, Yuanling; Xu, Yanli; Jian, Fanchong; Song, Weiliang; Yisimayi, Ayijiang; Wang, Peng; Wang, Jing; Liu, Jingyi; Yu, Lingling; Niu, Xiao; Wang, Jing; Wang, Yao; Shao, Fei; Jin, Ronghua; Wang, Youchun; Cao, Yunlong.
Afiliação
  • Yang S; Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing 100871, China; Changping Laboratory, Beijing, China; Peking-Tsinghua Center for Life Sciences, Tsinghua University, Beijing, China.
  • Yu Y; Changping Laboratory, Beijing, China.
  • Xu Y; Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Jian F; Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing 100871, China; College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, China; Changping Laboratory, Beijing, China.
  • Song W; Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing 100871, China; School of Life Sciences, Peking University, Beijing 100871, China; Changping Laboratory, Beijing, China.
  • Yisimayi A; Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing 100871, China; School of Life Sciences, Peking University, Beijing 100871, China; Changping Laboratory, Beijing, China.
  • Wang P; Changping Laboratory, Beijing, China.
  • Wang J; Changping Laboratory, Beijing, China.
  • Liu J; Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing 100871, China; College of Future Technology, Peking University, Beijing 100871, China; Changping Laboratory, Beijing, China.
  • Yu L; Changping Laboratory, Beijing, China.
  • Niu X; Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing 100871, China; School of Life Sciences, Peking University, Beijing 100871, China; Changping Laboratory, Beijing, China.
  • Wang J; Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing 100871, China; School of Life Sciences, Peking University, Beijing 100871, China; Changping Laboratory, Beijing, China.
  • Wang Y; Changping Laboratory, Beijing, China.
  • Shao F; Changping Laboratory, Beijing, China.
  • Jin R; Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Wang Y; Changping Laboratory, Beijing, China; Institute of Medical Biology, Chinese Academy of Medical Science and Peking Union Medical College, Kunming, China.
  • Cao Y; Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing 100871, China; School of Life Sciences, Peking University, Beijing 100871, China; Changping Laboratory, Beijing, China. Electronic address: yunlongcao@pku.edu.cn.
Lancet Infect Dis ; 24(2): e70-e72, 2024 Feb.
Article em En | MEDLINE | ID: mdl-38109919
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article